Summary
Wise shares tumbled on July 27, 2026, after a US regulator denied the company's banking licence application, marking a significant setback for the London-based cross-border payments firm. The denial represents a major regulatory hurdle for Wise's US expansion ambitions and sent shockwaves through the fintech sector.
The company had been pursuing a US banking charter to expand its services in the world's largest economy, aiming to offer a broader range of financial products directly to American consumers and businesses. The regulator's decision effectively blocks that path, at least for now.
Key Facts
- Wise shares fell sharply following the US regulator's denial of its banking licence application
- The denial blocks Wise's ability to offer full banking services in the US market
- Wise had been pursuing the charter to expand beyond its core cross-border payments business
- The company may explore alternative regulatory pathways, including the GENIUS Act framework
- The decision comes amid a broader regulatory tightening on fintech-bank partnerships in the US
Why It Matters
The denial is a significant blow to Wise's US growth strategy. The US is the world's largest cross-border payments market, and a banking licence would have allowed Wise to offer deposit accounts, lending, and other services directly — dramatically expanding its addressable market and revenue per customer. Without it, Wise must continue operating through partner banks, which limits product flexibility and margin potential.
The decision also signals that US regulators remain cautious about granting banking charters to fintech firms, even well-established ones like Wise. This could have broader implications for other fintechs pursuing similar strategies, including Revolut, Upstart, and others seeking US banking licences.